Janani Ravi

1.5k total citations
24 papers, 1.1k citations indexed

About

Janani Ravi is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Janani Ravi has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Janani Ravi's work include Bacteriophages and microbial interactions (4 papers), Cannabis and Cannabinoid Research (4 papers) and Genomics and Phylogenetic Studies (4 papers). Janani Ravi is often cited by papers focused on Bacteriophages and microbial interactions (4 papers), Cannabis and Cannabinoid Research (4 papers) and Genomics and Phylogenetic Studies (4 papers). Janani Ravi collaborates with scholars based in United States, India and Germany. Janani Ravi's co-authors include Ramesh K. Ganju, Mohd W. Nasser, Bandana Chakravarti, Mohamad Elbaz, Konstantin Shilo, Nissar Ahmad Wani, Dinesh K. Ahirwar, William E. Carson, Helong Zhao and Maria Laura Gennaro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Janani Ravi

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janani Ravi United States 15 472 348 179 134 129 24 1.1k
Yanying Zhao China 18 458 1.0× 116 0.3× 126 0.7× 158 1.2× 46 0.4× 60 1.2k
Yuxi Liu China 20 342 0.7× 89 0.3× 125 0.7× 68 0.5× 110 0.9× 84 1.0k
Renato S.B. Cordeiro Brazil 24 498 1.1× 207 0.6× 462 2.6× 181 1.4× 76 0.6× 86 1.6k
Lei Zhai China 20 443 0.9× 95 0.3× 134 0.7× 98 0.7× 58 0.4× 44 1.4k
Evros Vassiliou United States 14 257 0.5× 135 0.4× 352 2.0× 110 0.8× 109 0.8× 26 1.1k
Gladys Arreaza United States 14 346 0.7× 673 1.9× 147 0.8× 107 0.8× 71 0.6× 19 1.3k
Kuniyasu Soda Japan 21 1.1k 2.4× 286 0.8× 190 1.1× 76 0.6× 79 0.6× 42 1.6k
Zhengxiang Liu China 22 415 0.9× 63 0.2× 116 0.6× 97 0.7× 75 0.6× 70 1.0k
Loretta A. Bober United States 17 493 1.0× 264 0.8× 414 2.3× 27 0.2× 129 1.0× 29 1.4k

Countries citing papers authored by Janani Ravi

Since Specialization
Citations

This map shows the geographic impact of Janani Ravi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janani Ravi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janani Ravi more than expected).

Fields of papers citing papers by Janani Ravi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janani Ravi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janani Ravi. The network helps show where Janani Ravi may publish in the future.

Co-authorship network of co-authors of Janani Ravi

This figure shows the co-authorship network connecting the top 25 collaborators of Janani Ravi. A scholar is included among the top collaborators of Janani Ravi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janani Ravi. Janani Ravi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravi, Janani, et al.. (2025). Unlocking antimicrobial resistance with multiomics and machine learning. Trends in Microbiology. 33(10). 1048–1051. 3 indexed citations
2.
Ravi, Janani, et al.. (2024). The phage shock protein (PSP) envelope stress response: discovery of novel partners and evolutionary history. mSystems. 9(6). e0084723–e0084723. 10 indexed citations
3.
Ravi, Janani, et al.. (2024). Modeling the START transition in the budding yeast cell cycle. PLoS Computational Biology. 20(8). e1012048–e1012048.
4.
Delekta, Phillip C., Christopher Cooper, Daniel Havlichek, et al.. (2023). The glutathione import system satisfies the Staphylococcus aureus nutrient sulfur requirement and promotes interspecies competition. PLoS Genetics. 19(7). e1010834–e1010834. 5 indexed citations
5.
Alizadeh, Elaheh, Janani Ravi, Arminja N. Kettenbach, et al.. (2023). Feedback in the β-catenin destruction complex imparts bistability and cellular memory. Proceedings of the National Academy of Sciences. 120(2). 9 indexed citations
6.
Ravi, Janani, et al.. (2022). Novel internalin P homologs in Listeria. Microbial Genomics. 8(7). 1 indexed citations
7.
Ravi, Janani, et al.. (2022). DciA Helicase Operators Exhibit Diversity across Bacterial Phyla. Journal of Bacteriology. 204(8). e0016322–e0016322. 5 indexed citations
8.
Severin, Geoffrey B., Benjamin J. Ridenhour, Kristin N. Parent, et al.. (2022). Phage defence by deaminase-mediated depletion of deoxynucleotides in bacteria. Nature Microbiology. 7(8). 1210–1220. 59 indexed citations
9.
Ravi, Janani & Antonella Fioravanti. (2021). S-layers: The Proteinaceous Multifunctional Armors of Gram-Positive Pathogens. Frontiers in Microbiology. 12. 663468–663468. 16 indexed citations
10.
Simonsen, Vera, Lucilaine Ferrazoli, Daniel Antunes Maciel Villela, et al.. (2021). Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population. Scientific Reports. 11(1). 1224–1224. 3 indexed citations
11.
Ravi, Janani, Vivek Anantharaman, L. Aravind, & Maria Laura Gennaro. (2018). Variations on a theme: evolution of the phage-shock-protein system in Actinobacteria. Antonie van Leeuwenhoek. 111(5). 753–760. 4 indexed citations
12.
Ravi, Janani, Mohamad Elbaz, Nissar Ahmad Wani, Mohd W. Nasser, & Ramesh K. Ganju. (2016). Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway. Molecular Carcinogenesis. 55(12). 2063–2076. 74 indexed citations
13.
Elbaz, Mohamad, Dinesh K. Ahirwar, Janani Ravi, Mohd W. Nasser, & Ramesh K. Ganju. (2016). Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer. Oncotarget. 8(18). 29668–29678. 41 indexed citations
14.
Ravi, Janani, Pratik Datta, Dirk Schnappinger, et al.. (2016). Reconstruction and topological characterization of the sigma factor regulatory network of Mycobacterium tuberculosis. Nature Communications. 7(1). 11062–11062. 51 indexed citations
15.
Nasser, Mohd W., Nissar Ahmad Wani, Dinesh K. Ahirwar, et al.. (2015). RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment. Cancer Research. 75(6). 974–985. 124 indexed citations
16.
Elbaz, Mohamad, Mohd W. Nasser, Janani Ravi, et al.. (2015). Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer. Molecular Oncology. 9(4). 906–919. 181 indexed citations
17.
Datta, Pratik, Janani Ravi, Valentina Guerrini, et al.. (2015). The Psp system of Mycobacterium tuberculosis integrates envelope stress‐sensing and envelope‐preserving functions. Molecular Microbiology. 97(3). 408–422. 41 indexed citations
18.
Zhang, Mei, et al.. (2012). Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia. Indian Journal of Urology. 28(4). 377–377. 22 indexed citations
19.
Nasser, Mohd W., Zahida Qamri, Yadwinder S. Deol, et al.. (2011). S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways. Cancer Research. 72(3). 604–615. 104 indexed citations
20.
Sidhu, Jiwan S., Janani Ravi, & J. L. Minocha. (1984). Peroxidase isozyme patterns in primary trisomics of pearl millet. Theoretical and Applied Genetics. 68-68(1-2). 179–182. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026